BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12187956)

  • 21. Anaplasia in pilocytic astrocytoma predicts aggressive behavior.
    Rodriguez FJ; Scheithauer BW; Burger PC; Jenkins S; Giannini C
    Am J Surg Pathol; 2010 Feb; 34(2):147-60. PubMed ID: 20061938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
    Hara A; Saegusa M; Ichinoe M; Okayasu I
    J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for anaplastic astrocytomas.
    Compostella A; Tosoni A; Blatt V; Franceschi E; Brandes AA
    J Neurooncol; 2007 Feb; 81(3):295-303. PubMed ID: 17001519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent astrocytic tumours--a study of p53 immunoreactivity and malignant progression.
    Sarkar C; Ralte AM; Sharma MC; Mehta VS
    Br J Neurosurg; 2002 Aug; 16(4):335-42. PubMed ID: 12389885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases.
    Avninder S; Sharma MC; Deb P; Mehta VS; Karak AK; Mahapatra AK; Sarkar C
    J Neurooncol; 2006 Jun; 78(2):123-7. PubMed ID: 16614946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.
    Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H
    J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.
    Zhang F; Liu Y; Zhang Z; Li J; Wan Y; Zhang L; Wang Y; Li X; Xu Y; Fu X; Zhang X; Zhang M; Zhang Z; Zhang J; Yan Q; Ye J; Wang Z; Chen CD; Lin W; Li Q
    Sci Rep; 2016 Feb; 6():20882. PubMed ID: 26864347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival.
    Hilton DA; Penney M; Evans B; Sanders H; Love S
    Am J Surg Pathol; 2002 Apr; 26(4):472-8. PubMed ID: 11914625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study.
    Habberstad AH; Gulati S; Torp SH
    Diagn Pathol; 2011 May; 6():43. PubMed ID: 21609421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical markers for prognosis of ependymal neoplasms.
    Korshunov A; Golanov A; Timirgaz V
    J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
    Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
    Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors.
    Kato Y; Hayatsu N; Kaneko MK; Ogasawara S; Hamano T; Takahashi S; Nishikawa R; Matsutani M; Mishima K; Narimatsu H
    Biochem Biophys Res Commun; 2008 May; 369(4):1041-6. PubMed ID: 18329383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
    Perry A; Jenkins RB; O'Fallon JR; Schaefer PL; Kimmel DW; Mahoney MR; Scheithauer BW; Smith SM; Hill EM; Sebo TJ; Levitt R; Krook J; Tschetter LK; Morton RF; Buckner JC
    Cancer; 1999 Aug; 86(4):672-83. PubMed ID: 10440696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.
    Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Saito T; Matsuura S; Yamasaki F; Arita K; Kurisu K
    J Neurooncol; 2006 May; 77(3):273-7. PubMed ID: 16614947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
    Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
    Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time quantification of the proliferative state in astrocytomas.
    Ricco R; Cimmino A; Renzulli G; Serio G; Lozupone A; Lettini T; Pece A; Giardina C; Delfino VP
    Anal Quant Cytol Histol; 2000 Jun; 22(3):213-7. PubMed ID: 10872037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.